IBJNews

Eli Lilly's shares slip after it forecasts mixed profits in coming years

Back to TopCommentsE-mailPrintBookmark and Share

Investors dumped stock in Eli Lilly and Co. this morning after the company issued a long-term forecast that suggested its profit could tumble after patents expire on several of its bestselling drugs.

Lilly shares fell as much as 4.9 percent, to $34.76 each,  before recovering partially in late-morning trading.

The Indianapolis-based drugmaker expects to post profit of more than $3 billion each year from 2012 to 2014, according to Chief Financial Officer Derica Rice. Those are the years in which Lilly’s blockbusters Zyprexa, Cymbalta, Gemzar, Humalog and Evista could face competition from cheaper generic drugs.

But profit this year is on pace to exceed $4.5 billion and could approach $5 billion.

Lilly spokesman Phil Johnson emphasized that the $3 billion figure is a “minimum threshold.”

Lilly said it expects its earnings per share to grow in the double-digit range through 2011. The drugmaker expects to earn $4.65 to $4.85 per share in 2010, excluding the impact of health care reform and other items. On average, analysts expect income of $4.74 per share, according to a survey by Thomson Reuters.

Lilly said it would launch two new drugs each year beginning in 2013. The company has more than 60 molecules in clinical development, including 25 in mid- and late-stage development.

But since the blockbusters that will lose patent protection make up more than half of Lilly’s current revenue, investors and analysts do not think Lilly’s pipeline can make up the losses.

“Although Lilly has a growing mid-stage pipeline, these assets remain several years away from the market, leaving the company in the difficult position of needing to heavily invest in its next wave of product opportunities at a time of significant erosion,” Chris Schott, a JPMorgan Securities analyst, wrote to clients today, according to Bloomberg News.

In August, Lilly debuted blood thinner Effient in the United States, the company's first new product launch since 2005.

Lilly's fastest-growing product is Alimta, which saw its sales climb 47 percent in the third quarter. Lilly said Thursday it plans to pursue additional indications for the cancer drug, either as monotherapy, or in combination with other oncolytics.

Earlier this year, the Indianapolis company said it would cut annual costs by $1 billion by 2011 by trimming 5,500 workers (13.5 percent of its work force) and producing new drugs faster. Today, Lilly said its U.S. sales force would be 25 percent smaller in 2010 than it was at the beginning of 2009.

Lilly CEO John Lechleiter opened the investor meeting with a presentation meant to convince investors that Lilly’s high-risk strategy is the right one to take.

“We want you to leave this meeting sharing our confidence in our future prospect,” he said.

ADVERTISEMENT

  • Zyprexa litigation

    Eli Lilly sells a drug (Zyprexa) that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!

    Eli Lilly has made $38 billion on Zyprexa and it was way oversold and caused diabetes and in some cases sudden death.
    Eli Lilly has received a huge criminal fine over their Zyprexa cash cow,add it all up comes to $4.6 billion, in Zyprexa settlements,fines,litigation.

    Did you know that Lilly made $ billions last year on diabetic meds, Actos,Humulin and Byetta?

    They sell a drug that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!

    ----
    Daniel Haszard Zyprexa whistle-blower

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. So much for Eric Holder's conversation about race. If white people have got something to say, they get sued over it. Bottom line: white people have un-freer speech than others as a consequence of the misnamed "Civil rights laws."

  2. I agree, having seen three shows, that I was less than wowed. Disappointing!!

  3. Start drilling, start fracking, and start using our own energy. Other states have enriched their citizens and nearly elminated unemployment by using these resources that are on private land. If you are against the 'low prices' of discount stores, the best way to allow shoppers more choice is to empower them with better earnings. NOT through manipulated gov mandated min wage hikes, but better jobs and higher competitive pay. This would be direct result of using our own energy resources, yet Obama knows that Americans who arent dependent of gov welfare are much less likely to vote Dem, so he looks for ways to ensure America's decline and keep its citizens dependent of gov.

  4. Say It Loud, I'm Black and Ashamed: It's too bad that with certain "black" entertainment events, it seems violence and thuggery follows and the collateral damage that it leaves behinds continues to be a strain on the city in terms of people getting hurt, killed or becoming victims of crimes and/or stretching city resources. I remember shopping in the Meadows area years ago until violence and crime ended make most of the business pack you and leave as did with Lafayette Square and Washington Square. Over the past 10 to 12 years, I remember going to the Indiana Black Expo Soul Picnic in Washington Park. Violence, gang fights and homicides ended that. My great grandmother still bears the scares on her leg from when she was trampled by a group of thugs running from gun fire from a rival gang. With hundreds of police offices downtown still multiple shootings, people getting shot downtown during Black Expo. A number of people getting shots or murdered at black clubs around the city like Club Six on the west side, The Industry downtown, Jamal Tinsley's shot out in front of the Conrad, multiple fights and shootings at the skating rinks, shootings at Circle Center Mall and shooting and robberies and car jackings at Lafayette Mall. Shootings and gang violence and the State Fair. I can go on and on and on. Now Broad Ripple. (Shaking head side to side) Say It Loud, I'm Black and I'm Ashamed.

  5. Ballard Administration. Too funny. This is the least fiscally responsive administration I have ever seen. One thing this article failed to mention, is that the Hoosier State line delivers rail cars to the Amtrak Beech Grove maintenance facility for refurbishment. That's an economic development issue. And the jobs there are high-paying. That alone is worth the City's investment.

ADVERTISEMENT